Literature DB >> 26832629

Streptozotocin-induced diabetes, and the optic nerve blood barrier.

R Alemán1, B Mompeó2, I Castaño2.   

Abstract

OBJECTIVE: To study the features of the endoneurial micro-vessels of the optic nerve in streptozotocin-induced diabetic animals.
METHODS: Optic nerves from control and streptozotocin-induced diabetic animals were studied by light and transmission electron microscopy. Patency was determined by indirect immunofluorescence albumin detection. The expression of major histocompatibility complex class II molecules was performed by direct immunofluorescence. The endoneurial vessels were counted, and the endothelial cell, the basement membrane, and the surface of the transverse section of the nerve were measured.
RESULTS: Vessels of diabetic rats showed vessel wall thickening, preservation of pericytes, an increase in endothelial cell transcytosis, and an increased number of perivascular macrophage cells. It may be concluded that the effects of hyperglycaemia on the inner vessels of the optic nerve are more similar to the cerebral diabetic vessels than to the retinal vessels in diabetic animals.
Copyright © 2016 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Diabetes; Hiperglucemia; Hyperglycaemia; Nervio óptico; Optic nerve; Patency; Permeabilidad; Vasos; Vessels

Mesh:

Substances:

Year:  2016        PMID: 26832629     DOI: 10.1016/j.oftal.2015.12.017

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  2 in total

1.  In Vivo Evaluation of the Visual Pathway in Streptozotocin-Induced Diabetes by Diffusion Tensor MRI and Contrast Enhanced MRI.

Authors:  Swarupa Kancherla; William J Kohler; Yolandi van der Merwe; Kevin C Chan
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

2.  Glial Cells and Retinal Nerve Fibers Morphology in the Optic Nerves of Streptozotocin-induced Hyperglycemic Rats.

Authors:  Rafael Aleman-Flores; Blanca Mompeo-Corredera
Journal:  J Ophthalmic Vis Res       Date:  2018 Oct-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.